Informatie:
Fout:
ID
36695
Beschrijving
Pancreatic Nutritional Program for Weight Loss in Overweight/Obese Patients With Stage I-III Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02432950
Link
https://clinicaltrials.gov/show/NCT02432950
Trefwoorden
Versies (1)
- 02-06-19 02-06-19 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
2 juni 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Obesity NCT02432950
Eligibility Obesity NCT02432950
- StudyEvent: Eligibility
Similar models
Eligibility Obesity NCT02432950
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Early-Stage Breast Carcinoma TNM Breast tumor staging
Item
patients with early-stage breast cancer (stage i-iii)
boolean
C2986665 (UMLS CUI [1,1])
C0474926 (UMLS CUI [1,2])
C0474926 (UMLS CUI [1,2])
Chemotherapy | Chemotherapy Absent | Adjuvant Chemotherapy Completed
Item
patients who have or have not undergone chemotherapy are both eligible; if the patient has undergone chemotherapy she must have completed adjuvant chemotherapy for >= 3 months and =< 5 years prior to study enrollment
boolean
C0392920 (UMLS CUI [1])
C0392920 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0085533 (UMLS CUI [3,1])
C0205197 (UMLS CUI [3,2])
C0392920 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0085533 (UMLS CUI [3,1])
C0205197 (UMLS CUI [3,2])
Postmenopausal state | Natural menopause | Menopause Chemotherapy Induced | Follicle stimulating hormone level Postmenopausal state | Estradiol level Postmenopausal state
Item
postmenopausal women defined by either: natural menopause with at least one year since last menses, or chemotherapy-induced menopause with at least one year since last menses and follicle-stimulating hormone (fsh) and estradiol levels within the postmenopausal range
boolean
C0232970 (UMLS CUI [1])
C0856856 (UMLS CUI [2])
C0025320 (UMLS CUI [3,1])
C0392920 (UMLS CUI [3,2])
C0205263 (UMLS CUI [3,3])
C0428406 (UMLS CUI [4,1])
C0232970 (UMLS CUI [4,2])
C1443016 (UMLS CUI [5,1])
C0232970 (UMLS CUI [5,2])
C0856856 (UMLS CUI [2])
C0025320 (UMLS CUI [3,1])
C0392920 (UMLS CUI [3,2])
C0205263 (UMLS CUI [3,3])
C0428406 (UMLS CUI [4,1])
C0232970 (UMLS CUI [4,2])
C1443016 (UMLS CUI [5,1])
C0232970 (UMLS CUI [5,2])
Body mass index
Item
body mass index (bmi) of 25-33 kg/m^2
boolean
C1305855 (UMLS CUI [1])
Hormone Therapy Adjuvant
Item
patients undergoing current adjuvant endocrine therapy are eligible
boolean
C0279025 (UMLS CUI [1,1])
C1522673 (UMLS CUI [1,2])
C1522673 (UMLS CUI [1,2])
Adherence Program Pancreatic Nutritional | Protocol Compliance
Item
patients must be willing to adhere to the pnp intervention and the entire 6-month study
boolean
C1510802 (UMLS CUI [1,1])
C3484370 (UMLS CUI [1,2])
C0030274 (UMLS CUI [1,3])
C1521739 (UMLS CUI [1,4])
C0525058 (UMLS CUI [2])
C3484370 (UMLS CUI [1,2])
C0030274 (UMLS CUI [1,3])
C1521739 (UMLS CUI [1,4])
C0525058 (UMLS CUI [2])
Informed Consent
Item
all patients must have the ability and the willingness to sign a written informed consent
boolean
C0021430 (UMLS CUI [1])
Diabetic
Item
patients who are diabetic
boolean
C0241863 (UMLS CUI [1])
Body mass index Ineligible
Item
patients whose bmi falls outside the eligible range (< 25 kg/m^2 or > 33 kg/m^2)
boolean
C1305855 (UMLS CUI [1,1])
C1512714 (UMLS CUI [1,2])
C1512714 (UMLS CUI [1,2])
Breast Carcinoma TNM Breast tumor staging
Item
patients with stage iv breast cancer
boolean
C0678222 (UMLS CUI [1,1])
C0474926 (UMLS CUI [1,2])
C0474926 (UMLS CUI [1,2])